Andrew Kollath | CROmed Research

Our Events

Our events

Because of the COVID-19 pandemic, we prefer to hold all our meetings currently via video or phone conferences. However all our laboratory services are alive and can be used.

We are actively working with national and international partners to create better therapies and nutrition-based preventive possibilities for decreasing infections and ameliorating moderate COVID symptoms.

Post-COVID autoimmune disorders will mean a great burden for all societies so we have initiated an in-house program in this field. All partners and interested scientists are invited to join.

We are also proud to be members of the team that produced the first direct images of the native SARS-CoV-2 virion: https://www.biorxiv.org/content/10.1101/2020.09.17.302380v1.

Our latest publication

OUR LATEST PUBLICATION

Development of Polymer-Encapsulated, Amine-Functionalized Zinc Ferrite Nanoparticles as MRI Contrast Agents. - Int J Mol Sci, 2023 Nov 11.

Related Publications

RELATED PUBLICATIONS

Tumor growth, angiogenesis, cell adhesion

Netrin-4 promotes mural cell adhesion and recruitment to endothelial cells

Video

Partnerships

CROmed as a science-based enterprise partners with high-level academic institutions in Europe, Asia and the US. We develop new imaging tools, image analysis methods together. We have access to latest radiopharmaceuticals and fluorophores and we share scientific output. Read More…

Mission and vision

Our company is run by scientists and we strive to give all necessary clues to your succesful discovery and development. As we are a partner with ideas, we bring new insights to study planning and data management of our partners. Read More…

About us

CROmed Research and Services Ltd. is a dynamic, research oriented enterprise offering solutions in biomedicine and imaging.
We have wide experience in many research areas. Our team and ideas work together for your success. Read More…